RT Journal Article
SR Electronic
T1 773 A phase I/II study to evaluate the safety, tolerability and preliminary efficacy of GLS-012 monotherapy and in combination with zimberelimab in patients with advanced melanoma (Triumph-01)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A870
OP A870
DO 10.1136/jitc-2023-SITC2023.0773
VO 11
IS Suppl 1
A1 Guo, Jun
A1 Si, Lu
A1 Zhu, Jiman
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A870.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.